Immunome, Inc. · NASDAQ:IMNM
Barchas Isaac sold 36,088 Immunome, Inc. shares (Form 4)
Traded Aug 6 to Aug 7, 2026 · Filed Aug 10, 2026
From Aug 6 to Aug 7, 2026, Barchas Isaac (Director) sold 36,088 Immunome, Inc. shares at US$26.06 for US$940K under a trading plan, leaving 72,416 shares. Filed Aug 10, 2026 (Form 4).
- Sold
- 36,088 shares
- Price
- US$26.06
- Value
- US$940K
- Holding after
- 72,416 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | Sale | 20,840 | US$26.06 | 87,664 | Indirect |
| Aug 7, 2026 | Common Stock | Sale | 15,248 | US$26.06 | 72,416 | Indirect |
Source
Related
- Immunome, Inc.
- Barchas Isaac
- Immunome, Inc. shareholders
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Jul 7, 2026
- Form 4 · Barchas Isaac · Jul 2, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Horn Kinney · Aug 6, 2026
- Form 4 · Horn Kinney · Jul 27, 2026